Annual CFF:
-$211.72M-$161.56M(-322.11%)Summary
- As of today, AMRX annual cash from financing is -$211.72 million, with the most recent change of -$161.56 million (-322.11%) on December 31, 2024.
- During the last 3 years, AMRX annual cash from financing has fallen by -$73.60 million (-53.28%).
- AMRX annual cash from financing is now -140.61% below its all-time high of $521.39 million, reached on December 1, 2015.
Performance
AMRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$41.69M-$2.52M(-6.44%)Summary
- As of today, AMRX quarterly cash from financing is -$41.69 million, with the most recent change of -$2.52 million (-6.44%) on June 30, 2025.
- Over the past year, AMRX quarterly cash from financing has dropped by -$6.60 million (-18.81%).
- AMRX quarterly cash from financing is now -108.91% below its all-time high of $467.98 million, reached on March 31, 2020.
Performance
AMRX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$234.33M-$6.60M(-2.90%)Summary
- As of today, AMRX TTM cash from financing is -$234.33 million, with the most recent change of -$6.60 million (-2.90%) on June 30, 2025.
- Over the past year, AMRX TTM cash from financing has dropped by -$151.09 million (-181.50%).
- AMRX TTM cash from financing is now -144.70% below its all-time high of $524.24 million, reached on September 1, 2015.
Performance
AMRX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMRX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -322.1% | -18.8% | -181.5% |
| 3Y3 Years | -53.3% | -100.9% | -108.8% |
| 5Y5 Years | -400.6% | +86.6% | -268.5% |
AMRX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -322.1% | at low | -168.3% | +54.9% | -367.2% | at low |
| 5Y | 5-Year | -256.7% | at low | -168.3% | +54.9% | -268.5% | +34.7% |
| All-Time | All-Time | -140.6% | at low | -108.9% | +86.6% | -144.7% | +34.7% |
AMRX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$41.69M(-6.4%) | -$234.33M(-2.9%) |
| Mar 2025 | - | -$39.17M(+35.9%) | -$227.73M(-7.6%) |
| Dec 2024 | -$211.72M(-322.1%) | -$61.13M(+33.8%) | -$211.72M(-136.4%) |
| Sep 2024 | - | -$92.35M(-163.2%) | -$89.55M(-7.6%) |
| Jun 2024 | - | -$35.09M(-51.5%) | -$83.24M(-37.8%) |
| Mar 2024 | - | -$23.16M(-137.9%) | -$60.41M(-20.4%) |
| Dec 2023 | -$50.16M(+51.4%) | $61.04M(+170.9%) | -$50.16M(+61.9%) |
| Sep 2023 | - | -$86.04M(-602.0%) | -$131.64M(-43.5%) |
| Jun 2023 | - | -$12.26M(+5.0%) | -$91.73M(+8.5%) |
| Mar 2023 | - | -$12.90M(+36.9%) | -$100.23M(+4.5%) |
| Dec 2022 | -$103.23M(+25.3%) | -$20.45M(+55.7%) | -$104.90M(+8.6%) |
| Sep 2022 | - | -$46.13M(-122.3%) | -$114.80M(-2.3%) |
| Jun 2022 | - | -$20.75M(-18.1%) | -$112.23M(+13.4%) |
| Mar 2022 | - | -$17.57M(+42.1%) | -$129.54M(+6.2%) |
| Dec 2021 | -$138.12M(-202.2%) | -$30.35M(+30.3%) | -$138.12M(-16.0%) |
| Sep 2021 | - | -$43.55M(-14.4%) | -$119.05M(-36.8%) |
| Jun 2021 | - | -$38.07M(-45.6%) | -$87.01M(+75.8%) |
| Mar 2021 | - | -$26.15M(-131.8%) | -$359.02M(-365.7%) |
| Dec 2020 | $135.11M(+419.5%) | -$11.28M(+2.0%) | $135.11M(-2.9%) |
| Sep 2020 | - | -$11.51M(+96.3%) | $139.09M(-2.7%) |
| Jun 2020 | - | -$310.08M(-166.3%) | $143.00M(-67.9%) |
| Mar 2020 | - | $467.98M(+6512.4%) | $445.54M(+1153.5%) |
| Dec 2019 | -$42.29M(-114.1%) | -$7.30M(+3.9%) | -$42.29M(+83.3%) |
| Sep 2019 | - | -$7.60M(-0.7%) | -$253.91M(-67.1%) |
| Jun 2019 | - | -$7.54M(+62.0%) | -$151.94M(-148.6%) |
| Mar 2019 | - | -$19.85M(+90.9%) | $312.84M(+4.5%) |
| Dec 2018 | $299.45M(+415.2%) | -$218.92M(-332.0%) | $299.45M(-41.7%) |
| Sep 2018 | - | $94.38M(-79.4%) | $513.84M(+42.4%) |
| Jun 2018 | - | $457.24M(+1475.3%) | $360.72M(+473.7%) |
| Mar 2018 | - | -$33.25M(-633.9%) | -$96.52M(-52.5%) |
| Dec 2017 | -$95.02M(-124.3%) | -$4.53M(+92.3%) | -$63.28M(+2.3%) |
| Sep 2017 | - | -$58.75M(-880.1%) | -$64.74M(-116.5%) |
| Dec 2016 | $391.78M(-24.9%) | - | - |
| Dec 2016 | - | -$5.99M(-101.5%) | $391.78M(-1.7%) |
| Sep 2016 | - | $388.06M(>+9900.0%) | $398.64M(+2312.7%) |
| Jun 2016 | - | $1.61M(-80.1%) | $16.52M(-84.8%) |
| Mar 2016 | - | $8.11M(+835.1%) | $108.60M(-79.2%) |
| Dec 2015 | $521.39M(+3517.2%) | $867.00K(-85.4%) | $521.39M(-0.5%) |
| Sep 2015 | - | $5.94M(-93.7%) | $524.24M(+0.8%) |
| Jun 2015 | - | $93.69M(-77.7%) | $519.83M(+21.3%) |
| Mar 2015 | - | $420.89M(>+9900.0%) | $428.41M(+2872.2%) |
| Dec 2014 | $14.41M(+60.8%) | $3.72M(+142.9%) | $14.41M(+10.6%) |
| Sep 2014 | - | $1.53M(-32.6%) | $13.04M(-2.2%) |
| Jun 2014 | - | $2.27M(-67.1%) | $13.33M(-6.8%) |
| Mar 2014 | - | $6.90M(+195.0%) | $14.31M(+59.7%) |
| Dec 2013 | $8.96M | $2.34M(+28.0%) | $8.96M(+2.3%) |
| Sep 2013 | - | $1.83M(-43.7%) | $8.76M(-36.2%) |
| Jun 2013 | - | $3.25M(+109.3%) | $13.72M(+7.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $1.55M(-27.3%) | $12.77M(-26.3%) |
| Dec 2012 | $17.32M(-18.7%) | $2.13M(-68.6%) | $17.32M(-2.6%) |
| Sep 2012 | - | $6.79M(+196.1%) | $17.77M(+34.4%) |
| Jun 2012 | - | $2.29M(-62.4%) | $13.23M(-28.1%) |
| Mar 2012 | - | $6.10M(+135.4%) | $18.39M(-13.7%) |
| Dec 2011 | $21.31M(-10.8%) | $2.59M(+15.5%) | $21.31M(-12.5%) |
| Sep 2011 | - | $2.24M(-69.9%) | $24.35M(+4.9%) |
| Jun 2011 | - | $7.45M(-17.4%) | $23.23M(-15.5%) |
| Mar 2011 | - | $9.02M(+60.1%) | $27.49M(+15.0%) |
| Dec 2010 | $23.90M(+416.1%) | $5.64M(+404.6%) | $23.90M(+20.6%) |
| Sep 2010 | - | $1.12M(-90.5%) | $19.81M(+3.5%) |
| Jun 2010 | - | $11.71M(+115.6%) | $19.15M(+889.4%) |
| Mar 2010 | - | $5.43M(+250.5%) | -$2.43M(+67.9%) |
| Dec 2009 | -$7.56M(+88.4%) | $1.55M(+240.7%) | -$7.56M(+17.3%) |
| Sep 2009 | - | $455.00K(+104.6%) | -$9.15M(+86.8%) |
| Jun 2009 | - | -$9.86M(-3410.1%) | -$69.56M(-16.5%) |
| Mar 2009 | - | $298.00K(+927.8%) | -$59.69M(+0.5%) |
| Dec 2008 | -$65.08M(-729.6%) | -$36.00K(+99.9%) | -$59.99M(-0.1%) |
| Sep 2008 | - | -$59.95M(>-9900.0%) | -$59.95M(-157.3%) |
| Dec 2007 | $10.34M(>+9900.0%) | - | - |
| Dec 2006 | -$15.00K(+99.9%) | - | - |
| Dec 2005 | -$29.71M(-202.8%) | - | - |
| Sep 2004 | - | -$125.00K(-100.1%) | $104.65M(+0.6%) |
| Jun 2004 | - | $99.99M(+9616.9%) | $104.06M(+280.3%) |
| Mar 2004 | - | $1.03M(-72.6%) | $27.37M(-5.3%) |
| Dec 2003 | $28.91M(+477.5%) | $3.76M(+626.2%) | $28.91M(+30.1%) |
| Sep 2003 | - | -$715.00K(-103.1%) | $22.22M(-3.0%) |
| Jun 2003 | - | $23.29M(+804.8%) | $22.92M(+528.6%) |
| Mar 2003 | - | $2.57M(+188.0%) | $3.65M(-27.2%) |
| Dec 2002 | $5.01M(-90.1%) | -$2.93M(>-9900.0%) | $5.01M(-66.7%) |
| Sep 2002 | - | -$21.00K(-100.5%) | $15.02M(-17.1%) |
| Jun 2002 | - | $4.02M(+2.2%) | $18.13M(-67.3%) |
| Mar 2002 | - | $3.93M(-44.5%) | $55.44M(+9.4%) |
| Dec 2001 | $50.69M(+61.5%) | $7.09M(+129.9%) | $50.69M(-14.2%) |
| Sep 2001 | - | $3.08M(-92.5%) | $59.07M(+5.0%) |
| Jun 2001 | - | $41.33M(+5177.0%) | $56.26M(+269.4%) |
| Mar 2001 | - | -$814.00K(-105.3%) | $15.23M(-51.5%) |
| Dec 2000 | $31.38M(+144.4%) | $15.47M(+5484.1%) | $31.38M(+30.4%) |
| Sep 2000 | - | $277.00K(-7.7%) | $24.07M(-0.1%) |
| Jun 2000 | - | $300.00K(-98.0%) | $24.10M(-3.7%) |
| Mar 2000 | - | $15.34M(+88.1%) | $25.02M(+94.9%) |
| Dec 1999 | $12.84M(+749.3%) | $8.15M(+2513.8%) | $12.84M(+129.4%) |
| Sep 1999 | - | $312.00K(-74.4%) | $5.60M(-6.7%) |
| Jun 1999 | - | $1.22M(-61.3%) | $6.00M(+26.8%) |
| Mar 1999 | - | $3.15M(+245.7%) | $4.73M(+212.8%) |
| Dec 1998 | $1.51M | $912.00K(+28.1%) | $1.51M(+152.0%) |
| Sep 1998 | - | $712.00K(+1583.3%) | $600.00K(+635.7%) |
| Jun 1998 | - | -$48.00K(+25.0%) | -$112.00K(-75.0%) |
| Mar 1998 | - | -$64.00K | -$64.00K |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual cash from financing year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual cash from financing?
The current annual cash from financing of AMRX is -$211.72M
What is the all-time high annual cash from financing for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual cash from financing is $521.39M
What is Amneal Pharmaceuticals, Inc. annual cash from financing year-on-year change?
Over the past year, AMRX annual cash from financing has changed by -$161.56M (-322.11%)
What is Amneal Pharmaceuticals, Inc. quarterly cash from financing?
The current quarterly cash from financing of AMRX is -$41.69M
What is the all-time high quarterly cash from financing for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly cash from financing is $467.98M
What is Amneal Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
Over the past year, AMRX quarterly cash from financing has changed by -$6.60M (-18.81%)
What is Amneal Pharmaceuticals, Inc. TTM cash from financing?
The current TTM cash from financing of AMRX is -$234.33M
What is the all-time high TTM cash from financing for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM cash from financing is $524.24M
What is Amneal Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
Over the past year, AMRX TTM cash from financing has changed by -$151.09M (-181.50%)